Polyrizon (NASDAQ:PLRZ) Shares Cross Above 50-Day Moving Average – Should You Sell?

Shares of Polyrizon Ltd. (NASDAQ:PLRZ – Get Free Report) crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $10.55 and traded as high as $10.86. Polyrizon shares last traded at $10.75, with a volume of 45,946 shares trading hands.

Analysts Set New Price Targets

Several brokerages recently weighed in on PLRZ. Weiss Ratings downgraded shares of Polyrizon from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, October 8th. Wall Street Zen lowered Polyrizon from a “hold” rating to a “sell” rating in a research note on Saturday, September 12th. One research analyst has rated the stock with a Sell rating. According to MarketBeat, Polyrizon has an average rating of “Sell”.

Read Our Latest Report on Polyrizon

Polyrizon Stock Performance

The firm has a 50 day moving average of $10.55 and a 200-day moving average of $12.62.

Polyrizon (NASDAQ:PLRZ – Get Free Report) last posted its quarterly earnings results on Monday, September 28th. The company reported ($0.40) earnings per share for the quarter.

About Polyrizon

(Get Free Report)

Polyrizon Ltd. is a biotechnology company focused on developing nasal gels and other intranasal products designed to help protect against airborne allergens, pathogens and pollutants. Its proprietary hydrogel technology is intended to form a physical barrier within the nasal cavity, potentially limiting contact between inhaled particles and nasal tissue.

The company’s development programs are aimed at applications such as allergic rhinitis and the prevention or reduction of exposure to respiratory viruses and other airborne irritants.

Featured Stories

Receive News & Ratings for Polyrizon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polyrizon and related companies with MarketBeat.com's FREE daily email newsletter.